ID   AGS/EPI
AC   CVCL_Y085
DR   cancercelllines; CVCL_Y085
DR   Wikidata; Q54748717
RX   PubMed=25169536;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:47898; 4'-epidoxorubicin (Epirubicin).
CC   Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 12
//
RX   PubMed=25169536; DOI=10.7314/APJCP.2014.15.16.6849;
RA   Felipe A.V., Moraes A.A., de Oliveira J., da Silva T.D., Forones N.M.;
RT   "Establishment and partial characterization of an epirubicin-resistant
RT   gastric cancer cell line with upregulated ABCB1.";
RL   Asian Pac. J. Cancer Prev. 15:6849-6853(2014).
//